Nanobac Pharmaceuticals, Incorporated (NNBP)

Market Cap	250.00
Revenue (ttm)	17.62K
Net Income (ttm)	-6.58M
Shares Out	249.51M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,000
Average Volume	144,968
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	-50.12
RSI	47.21
Earnings Date	n/a

About Nanobac Pharmaceuticals

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company’s diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and pol...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNBP

Financial Performance

In 2007, Nanobac Pharmaceuticals's revenue was $17,621, a decrease of -92.17% compared to the previous year's $225,086. Losses were -$6.58 million, 32.2% more than in 2006.